Evidence map›Paper›PMID 32742378›Full record

ArticleExperimental and therapeutic medicine2020

Identification of a novel mutation in CRYM in a Chinese family with hearing loss using whole-exome sequencing.

Min Wang, Qian Li, Anchun Deng, Xianbai Zhu, Junjie Yang

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. T3 levels and thyroid hormone signaling.Frontiers in endocrinology · 2022
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Min WangDepartment of Otorhinolaryngology and Head and Neck Surgery, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, P.R. China.
Qian LiDepartment of Otorhinolaryngology and Head and Neck Surgery, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, P.R. China.
Anchun DengDepartment of Otorhinolaryngology and Head and Neck Surgery, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, P.R. China.
Xianbai ZhuDepartment of Otorhinolaryngology and Head and Neck Surgery, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, P.R. China.
Junjie YangDepartment of Otorhinolaryngology and Head and Neck Surgery, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, P.R. China.
Army Medical University · CNXinqiao Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have identified ~50 genes that contribute to non-syndromic autosomal dominant sensorineural deafness (DFNA). However, in numerous families with hearing loss, the specific gene mutation remains to be identified. In the present study, the clinical characteristics and gene mutations were analyzed in a Chinese pedigree with hereditary hearing loss. The clinical characteristics of the family members were assessed and a detailed audiology function examination was performed. Whole-exome sequencing (WES) was performed to identify the gene mutation responsible for the hearing loss. Sanger sequencing was used to verify the candidate mutation detected in the family. The family consisted of 31 members, seven of whom were diagnosed with sensorineural deafness of varying degrees. No mutation was identified by the general deafness gene chip. However, a novel heterozygous mutation in exon 3 (c.152C>T; Pro51Leu) of the gene crystallin µ (CRYM) was identified by WES. This result was further verified by Sanger sequencing. Co-segregation of genotypes and phenotypes suggested that this novel mutation was instrumental for the hearing loss/DFNA. In conclusion, the present study identified a novel pathogenic mutation, NM_001888.5(CRYM): c.152C>T(Pro51Leu), associated with DFNA. This mutation has not been reported previously and further functional studies are warranted.

Indexed as

CRYMmutationsensorineural deafnesssequencing

Identifiers

PMID32742378
PMCPMC7388290
OpenAlexW3034729068

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.